
Yahoo · 14 de sept de 2026
History says you should avoid HIMS stock right now
Hims & Hers Health, Inc.
Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, Australia, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides personalized health and wellness products; over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, skincare, sexual health and wellness, and hair care under the Hims & Hers brand name; and laboratory testing services to measure a set of biomarkers. Additionally, it offers medical consultation, post-consultation support services, and delivery of laboratory testing results services. Further, the company provides treatments and products for various chronic conditions related to hormone health, weight loss, dermatology, and mental health. The company offers its products through retail partnerships, in stores, and online. The company was formerly known as Hims, Inc. and changed its name to Hims & Hers Health, Inc. in January 2021. The company was founded in 2017 and is based in San Francisco, California.
No hay suficientes datos históricos para mostrar el gráfico de HIMS.
Precio
$ 11.400
Var. %
-0,52%
Volumen operado
34.351
Precio HIMS
US$ 28,54
Teórico (precio / ratio)
HIMS ÷ 4
US$ 7,14
Sí, existe el CEDEAR de HIMS (Hims & Hers Health, Inc.) en la Bolsa de Comercio de Buenos Aires (BYMA). Su ticker local es HIMS.
El ticker del CEDEAR de Hims & Hers Health, Inc. en Argentina es HIMS. La acción subyacente cotiza en NYSE con el símbolo HIMS.
El CEDEAR HIMS tiene un ratio de 4:1. Eso significa que 4 CEDEARs equivalen a 1 acción de HIMS.
El CEDEAR HIMS cotiza hoy a $ 11.400 en pesos argentinos, con una variación diaria de -0,52%.
La acción subyacente HIMS (Hims & Hers Health, Inc.) cotiza a US$ 28,54 en su mercado de origen (NYSE).

Yahoo · 14 de sept de 2026
History says you should avoid HIMS stock right now

SeekingAlpha · 14 de sept de 2026
Hims & Hers shifts to branded distribution, pressuring margins and FCF despite growth; valuation looks rich. Click for more on HIMS stock.

Yahoo · 13 de sept de 2026
Hims & Hers Health is still growing rapidly, but whether that growth can translate into better economics could determine how much further the stock can climb.
Cotización
US$ 7,23
vs teórico
+1,33%
Cotización MEP implícita
$ 1.576,76
Cotización
US$ 7,29
vs teórico
+2,17%
Cotización Cable implícita
$ 1.563,79
El precio teórico del CEDEAR HIMS se calcula dividiendo el precio de HIMS por el ratio (4). Hoy resulta en US$ 7,14.
En BYMA podés operar HIMS en pesos, HIMSD en dólar MEP y HIMSC en dólar cable. Cada modalidad refleja un tipo de cambio distinto.
En esta página encontrás un gráfico con el precio histórico del CEDEAR HIMS en pesos argentinos, con datos de data912.

SeekingAlpha · 12 de sept de 2026
Wall Street Week Ahead: key market events, Fed rate decision, retail sales, earnings, IPOs, dividends & volatility watchlists. See more here.

Yahoo · 11 de sept de 2026
The weight-loss opportunity now comes with a margin tradeoff

Yahoo · 11 de sept de 2026
Investing.com -- JPMorgan revealed Friday that it has started coverage of Hims & Hers Health at Neutral, setting a December 2027 price target of $32 as it weigh…

Yahoo · 10 de sept de 2026
Pump.fun launches Custom Pairs, letting creators launch tokens against stocks, crypto, metals, and more while earning fees in the paired asset.

Yahoo · 9 de sept de 2026
Hims & Hers Health (HIMS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Noticias vía Finnhub